LEVETIRACETAM SOL. ORAL 100 MG./ML. FCO. C/300 ML. IMGN Tratamiento del carcinoma in situ

Description

Tratamiento del carcinoma in situ de vejiga

No indicado en casos de hipersensibilidad a Salbutamol u otros componentes

PRINCIPIO ACTIVO: CIPROFLOXACINO

FABRICANTE: QUIFA - PERRIGO OTC

LEVETIRACETAM SOL. ORAL 100 MG./ML. FCO. C/300 ML. IMGN Tratamiento del carcinoma in situLEVETIRACETAM 100. 00 MG

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy